E&G Advisors, LP Eli Lilly & CO Transaction History

E&G Advisors, LP

$415 Million
Q3 2025

A detailed history of E&G Advisors, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, E&G Advisors, LP holds 1,999 shares of LLY stock, worth $1.69 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

1,999

Previous 2,031 1.58%

Holding current value

$1.69 Million

Previous $1.58 Million 3.66%

% of portfolio

0.37%

Previous 0.42%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$625.65 - $812.69 $20,020 - $26,006	-32 Reduced 1.58%	1,999 $1.53 Million
Q1 2025 Apr 23, 2025	SELL	$725.72 - $929.72 $217,716 - $278,916	-300 Reduced 12.87%	2,031 $1.68 Million
Q4 2024 Jan 24, 2025	SELL	$727.2 - $932.06 $290,880 - $372,824	-400 Reduced 14.65%	2,331 $1.8 Million
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $138,985 - $172,803	180 Added 7.06%	2,731 $2.42 Million
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $592 - $792	1 Added 0.04%	2,551 $1.98 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $10,503 - $12,382	20 Added 0.79%	2,550 $1.49 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $86,940 - $119,859	-200 Reduced 7.33%	2,530 $1.36 Million
Q1 2023 Jul 20, 2023	SELL	$310.63 - $364.82 $124,252 - $145,928	-400 Reduced 12.78%	2,730 $937,000
Q1 2023 Apr 17, 2023	BUY	$310.63 - $364.82 $133,570 - $156,872	430 Added 15.93%	3,130 $1.07 Million
Q3 2021 Oct 20, 2021	BUY	$221.6 - $272.71 $598,320 - $736,317	2,700 New	2,700 $624,000
Q2 2021 Jul 12, 2021	SELL	$180.55 - $233.54 $487,485 - $630,558	-2,700 Closed	0 $620,000
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $98,592 - $127,632	-600 Reduced 18.18%	2,700 $504,000
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $26,092 - $34,526	200 Added 6.45%	3,300 $557,000
Q4 2019 Jan 10, 2020	SELL	$106.92 - $132.43 $42,768 - $52,972	-400 Reduced 11.43%	3,100 $407,000
Q4 2018 Jan 17, 2019	BUY	$105.9 - $118.64 $84,720 - $94,912	800 Added 29.63%	3,500 $405,000
Q3 2018 Oct 10, 2018	SELL	$85.86 - $107.31 $188,892 - $236,082	-2,200 Reduced 44.9%	2,700 $290,000
Q2 2018 Jul 30, 2018	BUY	$75.7 - $86.88 $37,850 - $43,440	500 Added 11.36%	4,900 $418,000
Q4 2017 Jan 16, 2018	BUY	$81.94 - $87.89 $360,536 - $386,716	4,400	4,400 $372,000

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.3M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $802B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E&G Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on E&G Advisors, LP with notifications on news.

Account